Table 2. Prevalence of extracutaneous complications and diabetic foot ulcer in patients with type 2 Diabetes mellitus.
| Variables | All patients N=160 |
Group I (HbA1c <7.0%) N=43 |
Group II (HbA1c ≥7.1) N=117 |
p value 0.001 |
|||
| Extracutaneous microvascular complications (N, %) | |||||||
| Yes | 85 | 53.1% | 13 | 30.2% | 72 | 61.5% | |
| No | 75 | 46.9% | 30 | 69.8% | 45 | 38.5% | |
| Polyneuropathy | 0.043 | ||||||
| Yes | 58 | 36.3% | 10 | 23.3% | 48 | 41.0% | |
| No | 102 | 63.7% | 33 | 76.7% | 69 | 59.0% | |
| Nephropathy | 0.004 | ||||||
| Yes | 49 | 30.6% | 6 | 14.0% | 43 | 36.8% | |
| No | 111 | 69.4% | 37 | 86.0% | 74 | 63.2% | |
| Retinopathy | 0.067 | ||||||
| Yes | 60 | 37.5% | 11 | 25.6% | 49 | 41.9% | |
| No | 100 | 62.5% | 32 | 74.4% | 68 | 58.1% | |
| Diabetic foot ulcer | 0.021 | ||||||
| Yes | 13 | 8.1% | 0 | 0.0% | 13 | 11.1% | |
| No | 147 | 91.9% | 43 | 100.0% | 104 | 88.9% |